Pillstats
Rx only · Tablet · Oral

Roflumilast

Brands: Daliresp · Roflumilast

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1091836
US makers17 labelers
Packages70
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 34 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.828$1.66$2.48$3.31Dec 2025Apr 2026Jul 2026
$2.567
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
17
Active US suppliers
26%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5.1K10K15K20K2025 Q12025 Q22025 Q32025 Q42026 Q1
16K
Rx · 2026 Q1
548K
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Micro Labs Limitedunknown9SUPPLYING
Ascend Laboratories, LLCunknown9SUPPLYING
AMICI PHARMA INCunknown6SUPPLYING
Novadoz Pharmaceuticals LLCunknown6SUPPLYING
Camber Pharmaceuticals, Inc.unknown5SUPPLYING
Major Pharmaceuticalsunknown5SUPPLYING
Zydus Lifesciences Limitedunknown4SUPPLYING
Aurobindo Pharma Limitedunknown4SUPPLYING
AstraZeneca Pharmaceuticals LPunknown4SUPPLYING
Jubilant Cadista Pharmaceuticals Inc.unknown4SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown4SUPPLYING
AvKAREunknown3SUPPLYING
Strides Pharma Science Limitedunknown2SUPPLYING
Solco Healthcare US, LLCunknown2SUPPLYING
American Health Packagingunknown1SUPPLYING

+ 2 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.